West Pharmaceutical Services Inc (NYSE: WST) has reported earnings for its third fiscal quarter (ending September 30) of $1.87 versus $2.17 for the same period a year ago — a decline of -14%. For the latest four quarters through September 30, E.P.S. were $6.81 compared to $7.51 a year ago — a decline of -9%.
Recent Price Action
On 10/24/24, West Pharmaceutical Services Inc (NYSE: WST) stock enjoyed a major increase of 15.4%, closing at $330.65. Moreover, trading volume in this advance was exceptionally high at 425% of normal. Relative to the market the stock has been weak over the last nine months but has risen 14.4% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to be above the cost of capital, WST is expected to continue to be a major Value Builder.
West Pharmaceutical Services has a current Value Trend Rating of F (Lowest Rating). This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. West Pharmaceutical Services has a poor Power Rating of 19 and a very low Appreciation Score of 13, with the Lowest Value Trend Rating the result.
Rating Review
In light of this new information and very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment